CUAMC
VERV

China Universal Asset Management Company’s Verve Therapeutics VERV Stock Holding History

China Universal Asset Management Company’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,904
Closed -$201K – 510
2025
Q2 		$201K Buy
17,904
+93
+0.5% +$530 0.02% 312
2025
Q1 		$81.4K Sell
17,811
-141
-0.8% -$944 0.01% 374
2024
Q4 		$101K Buy
17,952
+1,676
+10% +$9.45K 0.01% 388
2024
Q3 		$78.8K Buy
16,276
+6,412
+65% +$37.2K 0.01% 371
2024
Q2 		$48.1K Sell
9,864
-6,207
-39% -$39K 0.01% 360
2024
Q1 		$213K Buy
16,071
+7,256
+82% +$96.2K 0.03% 281
2023
Q4 		$123K Buy
8,815
+7,174
+437% +$88.9K 0.02% 257
2023
Q3 		$21.8K Buy
1,641
+829
+102% +$13.3K 0.01% 291
2023
Q2 		$15.2K Sell
812
-23
-3% -$383 ﹤0.01% 290
2023
Q1 		$12K Buy
835
+209
+33% +$4.09K ﹤0.01% 268
2022
Q4 		$12.1K Buy
626
+65
+12% +$1.72K ﹤0.01% 211
2022
Q3 		$19K Buy
+561
New +$17.9K 0.01% 161

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

China Universal Asset Management Company's VERV Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 17,904 shares — an estimated $201K sold.

China Universal Asset Management Company first reported a position in VERV in Q3 2022 and held it in 12 quarters. The position peaked at $213K in Q1 2024. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 17,904 Verve Therapeutics shares in Q3 2025, an estimated $201K.
  • China Universal Asset Management Company first reported a position in Verve Therapeutics in Q3 2022 and held it in 12 quarters.
  • China Universal Asset Management Company's Verve Therapeutics position peaked at $213K in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.